MedPath

Enhanced diabetes-cardiovascular management through primary health care in Pakista

Not Applicable
Completed
Conditions
Diabetes and cardiovascular disease
Nutritional, Metabolic, Endocrine
Non-insulin-dependent diabetes mellitus
Registration Number
ISRCTN23905886
Lead Sponsor
niversity of Leeds - COMDIS-HSD (UK)
Brief Summary

2018 results in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348328/ (added 04/11/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
495
Inclusion Criteria

1. All type 2 diabetes patients of both genders, age > 25 years
2. Resident of the catchment area of the respective facility (RHC/tehsil hospital)

Exclusion Criteria

1. Those not giving consent for the study
2. Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Glycaemic control among registered Type 2 diabetes cases. The case registration will be taken mainly from the Type 2 diabetes care register at each facility.<br> 2. The mean change in Hb1AC measurement, i.e change of mean HbA1c at 18 months of follow-up compared to the baseline (at registration), will be used for assessing the glycemic control.<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. To compare the mean treatment success (attending and HbA1Ac < 7.5%, or FBG <7)<br> 2. To compare the mean hypertension control (< 130/80) and total cholesterol (<200) achieved in the adult Type 2 diabetes patients, with associated hypertension and hyper-cholesterol conditions<br> 3. To conduct incremental cost effectiveness analysis of managing adult type 2 diabetes patients at Primary Health Care (PHC) facilities in Punjab, Pakistan<br> 4. To inform the provincial strategic plan for managing type 2 diabetes and associated hypertension and hyper-cholesterol conditions in Punjab<br>
© Copyright 2025. All Rights Reserved by MedPath